Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Do we know when the next AGM is being held please?
B.
Thanks for posting!
I would hardly call 20 trades 'lots' of selling....
B.
Clearly more funds will be needed and my hope is that the BoD won't wait until the 11th hour for this. Though I can seem there perhaps being a temptation to wait for the P1a results to strengthen their position.
Some on here are hoping for a SRA737 re-license deal with an up[front payment to the CPF and Sareum to address in part or in whole of this funding need. Its a nice idea and whilst I'm optimistic that a deal will materialise I feel it can't be taken to the bank. Thus my hope is that the BoD can arrange another HNWI style fund raising before too long as a safe option to ensure a good cash runway is there.
B.
Let’s see what transpires. But, I think that the minimum the BOD are likely to accept is the 25pence per share nominal value.
B.
Just seen the latest RNS. And I interpreting this correct.y? Have AVO received some kind of an offer?
£2
Well done, HBD!
It’s basically a repeat of the recent RNS.
Received a letter from AVO in the post today, regarding the possible sale into NASDAQ. Has anyone else received it?
B.
Two delayed trades from yesterday just showed at totalling a little over 16million shares. Maybe this is DCNA clearing the balance of their holding….
HBD: From my own review of the IP related clauses in the Sierra/CPF agreement, I believe the situation is:
1). The CPF gets a perpetual, 'do what ever they want with it' license to any 'arising IP'. With, in this case, the arising IP being the new 737 related patents that Sierra filed for.
2). This means that the CPF are free to on-license against those new patents.
Where things can potentially come apart, is if Sierra/GSK decide not to maintain these new patents and they lapse. In that case the new patents IP becomes free for anyone to use. I'm thus hoping that the CPF and Sierra/GSK work out some sort of commercial arrangement to make sure that doesn't happen. This is of course assuming that these new patents really do offer something of value.
Bill.
I think you are…
Market cap of £16M.
"BONKERS"
B.
They refused to comment on the rate of cash burn going forwards
The Edison note says that the MHRA turned down Sareum's CTA application. That seems incorrect, as from what I understand the process simply stalled with a review being required, that the MHRA are yet to follow up on. Or, have I misunderstood the situation?
B.
25% or 30% depending upon the size of company.
B
My understanding is that they will fund production through a mix of customer deposits and bank debt. ‘If’ they can get to the point of receiving firm orders with deposits paid I think the whole situation will improve dramatically. Thus noting the update in January I hope they are able to execute on concluding some sales and deposits as they eluded to be pursuing.
Bill
How do you know they were buys, Wastegatecatcher? The 700,000 shares @ 5.43p was definitely a buy. But looking at the 5p price for the two 918,260 share trades look like sells to me. Am I missing something?
When is the next dividend payment due?